Premium
QuantiFERON‐TB Gold conversion is not uncommon in patients with psoriasis undergoing anti‐tumour necrosis factor‐α therapy: reply from the author
Author(s) -
Fernandez A.P.
Publication year - 2020
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.19316
Subject(s) - psoriasis , medicine , dermatology , necrosis , tumor necrosis factor α , tumor necrosis factor alpha , surgery
Linked Articles: Megna et al. Br J Dermatol 2020; 183 :977–978. Ya et al. Br J Dermatol 2020; 182 :800–802.